Skip to content

Facilitators and Barriers in Workflow Integration of a web-based AI-Software in clinical care – An empirical investigation into the clinical application of Face2Gene for rare diseases with associated facial abnormalities

Facilitators and Barriers in Workflow Integration of a web-based AI-Software in clinical care – An empirical investigation into the clinical application of Face2Gene for rare diseases with associated facial abnormalities

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00032436
Enrollment
30
Registered
2023-08-10
Start date
2023-10-09
Completion date
Unknown
Last updated
2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Workflow integration of Face2Gene for the identification of rare diseases

Interventions

Group 1: This is a qualitative interview study with users from clinical practice.

Sponsors

Institut für Patientensicherheit, Universitätsklinikum Bonn
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. licensed physicians in human genetics or pediatrics at German university hospitals, as these disciplines are the primary application areas of Face2Gene. 2. German language level B2 or higher, as the interviews will be conducted in German.

Exclusion criteria

Exclusion criteria: 1. No contact with Face2Gene

Design outcomes

Primary

MeasureTime frame
The aim of this study is to conduct a post-hoc evaluation of the integration of the AI application Face2Gene into the clinical workflow. Specifically, this study aims to: (1) evaluate the workflow integration of Face2Gene at the level of medical professionals in different clinical work environments.

Secondary

MeasureTime frame
(2) Evaluate the usability of Face2Gene in various clinical settings. (3) Identify facilitators and barriers that influence the integration and adoption of an AI-based software in clinical practice. We aim to investigate challenges encountered during the implementation process and use of Face2Gene in routine clinical practice, with the goal of identifying strategies that may facilitate future implementation processes.

Countries

Germany

Contacts

Public ContactKatharina Wenderott

Institut für Patientensicherheit, Universitätsklinikum Bonn

katharina.wenderott@ukbonn.de+49 228 287 13781

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 5, 2026